HUB ORGANOID
LIVE

Serial Number

79276822

Owner

HUB Organoids IP B.V.

Attorney

William C. Wright

Filing Date

Oct 23, 2019

Add to watchlist:

No watchlists yet
View on USPTO

HUB ORGANOID Trademark

Serial Number: 79276822 • Registration: 6253487

HUB ORGANOID is a trademark filed by HUB Organoids IP B.V. on October 23, 2019. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

HUB Organoids IP B.V. (6 trademarks)

Yalelaan 62

Entity Type: 78

HUB Organoids B.V. IP (6 trademarks)

Yalelaan 62

Entity Type: 99

Stichting Hubrecht Organoid Technology (6 trademarks)

Yalelaan 62

Entity Type: 78

Trademark Details

Filing Date

October 23, 2019

Registration Date

January 26, 2021

Published for Opposition

November 10, 2020

Goods & Services

Scientific research; genetic testing for scientific research purposes; medical and pharmacological research services; pharmaceutical drug and vaccine development services; development of pharmaceutical preparations and medicines; medical compound, drug and vaccine discovery, development services, and characterization and validation services in the nature of product quality and efficacy testing for medical compounds, drugs and vaccines; candidate drug and vaccine, drug and vaccine testing services, namely, testing of pharmaceuticals; companion diagnostics, namely, the scientific testing and evaluation of drugs and vaccines for individuals or groups of patients to determine the safety and effectiveness of the drug or vaccine for those patients; food safety testing services; testing of compounds and substances to determine toxicity to cells and organoids, namely, self-organized three-dimensional tissue cultures derived from stem cells and cell cultures; scientific research and diagnostic services in the field of personalized medicine

Cells, stem cells, epithelial cells, all for scientific research purposes; organoids, namely, self-organized three-dimensional tissue cultures derived from stem cells and cell cultures, for scientific and research use; cell culture reagents for scientific and research use; cell culture media for scientific and research use; diagnostic preparations and reagents for use in science; chemicals used in science and industry; assays and assay reagents for scientific purposes; cell culture media for scientific research purposes

Cells for medical and veterinary, diagnostic and therapeutic purposes, namely, for diagnosis and treatment of diseases or disorders of epithelial tissue in the sensory, reproductive, urinary, digestive, circulatory, endocrine, nervous, lymphatic, integumentary, or respiratory systems; cells for medical and veterinary, diagnostic and therapeutic purposes, namely, for diagnosis and treatment of diseases of epithelial tissue in the liver, pancreas, intestine, stomach, prostate, lung, breast, kidney, ovarian, uterus, fallopian tube, sweat gland, hair follicle, skin, oesophagus, thyroid, nose, throat, sinus, trachea, oral cavity, salivary gland, larynx or pharynx; stem cells for medical and veterinary, diagnostic and therapeutic purposes, namely, for diagnosis and treatment of diseases or disorders of epithelial tissue in the sensory, reproductive, urinary, digestive, circulatory, endocrine, nervous, lymphatic, integumentary, or respiratory systems; stem cells for medical and veterinary, diagnostic and therapeutic purposes, namely, for diagnosis and treatment of diseases of epithelial tissue in the liver, pancreas, intestine, stomach, prostate, lung, breast, kidney, ovarian, uterus, fallopian tube, sweat gland, hair follicle, skin, oesophagus, thyroid, nose, throat, sinus, trachea, oral cavity, salivary gland, larynx or pharynx; epithelial cells for medical and veterinary, diagnostic and therapeutic purposes, namely, for diagnosis and treatment of diseases or disorders of epithelial tissue in the sensory, reproductive, urinary, digestive, circulatory, endocrine, nervous, lymphatic, integumentary, or respiratory systems; epithelial cells for medical and veterinary, diagnostic and therapeutic purposes, namely, for diagnosis and treatment of diseases of epithelial tissue in the liver, pancreas, intestine, stomach, prostate, lung, breast, kidney, ovarian, uterus, fallopian tube, sweat gland, hair follicle, skin, oesophagus, thyroid, nose, throat, sinus, trachea, oral cavity, salivary gland, larynx or pharynx; organoids, namely, self-organized three-dimensional tissue cultures derived from stem cells and cell cultures for medical and veterinary, diagnostic and therapeutic purposes, namely, for diagnosis and treatment of diseases or disorders of epithelial tissue in the sensory, reproductive, urinary, digestive, circulatory, endocrine, nervous, lymphatic, integumentary, or respiratory systems; organoids, namely, self-organized three-dimensional tissue cultures derived from stem cells and cell cultures for medical and veterinary, diagnostic and therapeutic purposes, namely, for diagnosis and treatment of diseases of epithelial tissue in the liver, pancreas, intestine, stomach, prostate, lung, breast, kidney, ovarian, uterus, fallopian tube, sweat gland, hair follicle, skin, oesophagus, thyroid, nose, throat, sinus, trachea, oral cavity, salivary gland, larynx or pharynx; cell cultures for medical and veterinary, diagnostic and therapeutic purposes, namely, cells grown in culture media for use in diagnosis and treatment of diseases or disorders of epithelial tissue in the sensory, reproductive, urinary, digestive, circulatory, endocrine, nervous, lymphatic, integumentary, or respiratory systems; cell cultures for medical and veterinary, diagnostic and therapeutic purposes, namely, cells grown in culture media for use in diagnosis and treatment of diseases of epithelial tissue in the liver, pancreas, intestine, stomach, prostate, lung, breast, kidney, ovarian, uterus, fallopian tube, sweat gland, hair follicle, skin, oesophagus, thyroid, nose, throat, sinus, trachea, oral cavity, salivary gland, larynx or pharynx; diagnostic and analytical preparations for medical purposes; biological tissue cultures for medical and veterinary purposes; assays and assay preparations for medical and veterinary diagnostic testing of cells, cultures and organoids for therapeutic purposes; pharmaceutical and veterinary preparations for diagnosis and treatment of diseases or disorders of epithelial tissue in the sensory, reproductive, urinary, digestive, circulatory, endocrine, nervous, lymphatic, integumentary, or respiratory systems; pharmaceutical and veterinary preparations for diagnosis and treatment of diseases of epithelial tissue in the liver, pancreas, intestine, stomach, prostate, lung, breast, kidney, ovarian, uterus, fallopian tube, sweat gland, hair follicle, skin, oesophagus, thyroid, nose, throat, sinus, trachea, oral cavity, salivary gland, larynx or pharynx; cells, epithelial cells, organoids and cell cultures for personalised medicine, namely, for diagnosis and treatment of diseases or disorders of epithelial tissue in the sensory, reproductive, urinary, digestive, circulatory, endocrine, nervous, lymphatic, integumentary, or respiratory systems; cells, epithelial cells, organoids and cell cultures for personalised medicine, namely, for diagnosis and treatment of diseases of epithelial tissue in the liver, pancreas, intestine, stomach, prostate, lung, breast, kidney, ovarian, uterus, fallopian tube, sweat gland, hair follicle, skin, oesophagus, thyroid, nose, throat, sinus, trachea, oral cavity, salivary gland, larynx or pharynx

Medical services and surgery; medical and surgical diagnostic services; medical services in the nature of cell transplantation services

Filing History

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Jan 26, 2026 REM3
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Oct 28, 2025 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Oct 28, 2025 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Oct 28, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Oct 28, 2025 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Oct 28, 2025 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Oct 28, 2025 COAR
CHANGE OF NAME/ADDRESS REC'D FROM IB
May 7, 2024 ADCH
CHANGE OF OWNER RECEIVED FROM IB
Apr 5, 2024 CHLD
FINAL DECISION TRANSACTION PROCESSED BY IB
May 23, 2021 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Apr 29, 2021 FICS
FINAL DISPOSITION PROCESSED
Apr 29, 2021 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Apr 26, 2021 FICR
REGISTERED-PRINCIPAL REGISTER
Jan 26, 2021 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 10, 2020 NPUB
PUBLISHED FOR OPPOSITION
Nov 10, 2020 PUBO
NOTIFICATION PROCESSED BY IB
Nov 8, 2020 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Oct 21, 2020 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Oct 21, 2020 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 21, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 2, 2020 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 25, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 25, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 25, 2020 TROA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Aug 24, 2020 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Aug 24, 2020 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Aug 24, 2020 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Aug 24, 2020 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Aug 24, 2020 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Aug 24, 2020 COAR
REFUSAL PROCESSED BY IB
Mar 21, 2020 RFNT
NEW REPRESENTATIVE AT IB RECEIVED
Mar 20, 2020 NREP
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Feb 26, 2020 RFCS
REFUSAL PROCESSED BY MPU
Feb 26, 2020 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Feb 5, 2020 RFCR
NON-FINAL ACTION WRITTEN
Feb 4, 2020 CNRT
APPLICATION FILING RECEIPT MAILED
Jan 31, 2020 MAFR
ASSIGNED TO EXAMINER
Jan 28, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 27, 2020 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jan 23, 2020 REPR